OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SIGIS–SIAMS–SIE position statement of gender affirming hormonal treatment in transgender and non-binary people
Alessandra D. Fisher, Giulia Senofonte, Carlotta Cocchetti, et al.
Journal of Endocrinological Investigation (2021) Vol. 45, Iss. 3, pp. 657-673
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

The Italian Society of Andrology and Sexual Medicine (SIAMS), along with ten other Italian Scientific Societies, guidelines on the diagnosis and management of erectile dysfunction
Giovanni Corona, Domenico Cucinotta, Giorgio Di Lorenzo, et al.
Journal of Endocrinological Investigation (2023) Vol. 46, Iss. 6, pp. 1241-1274
Open Access | Times Cited: 59

Risk assessment of transgender people: implementation of a demasculinizing–feminizing rodent model including the evaluation of thyroid homeostasis
Alessia Tammaro, Gabriele Lori, Andrea Martinelli, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 4

Effetti metabolici delle terapie di affermazione di genere
Marco Masi, Sara Muci, Francesco Giorgino, et al.
L Endocrinologo (2025)
Open Access

Bone health and body composition in transgender adults before gender-affirming hormonal therapy: data from the COMET study
Chiara Ceolin, Antonio Scala, Marinel Mór Dall’Agnol, et al.
Journal of Endocrinological Investigation (2023) Vol. 47, Iss. 2, pp. 401-410
Open Access | Times Cited: 10

Efficacy of topical minoxidil in enhancing beard growth in a group of transgender assigned female at birth individuals on gender affirming hormone therapy
Lorenzo Marinelli, Andreina Bichiri, Serena Cagnina, et al.
Journal of Endocrinological Investigation (2024) Vol. 47, Iss. 11, pp. 2843-2850
Open Access | Times Cited: 3

Apparent autistic traits in transgender people: a prospective study of the impact of gender-affirming hormonal treatment
Francesca Mazzoli, Emanuele Cassioli, Jiska Ristori, et al.
Journal of Endocrinological Investigation (2022) Vol. 45, Iss. 11, pp. 2059-2068
Open Access | Times Cited: 14

Regulation of drug-metabolizing enzymes by sex-related hormones: clinical implications for transgender medicine
An K. Le, Kai J. Huang, Lauren R. Cirrincione
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 7, pp. 582-592
Closed Access | Times Cited: 13

Effects of hormonal treatment on dermatological outcome in transgender people: a multicentric prospective study (ENIGI)
Carlotta Cocchetti, Giovanni Castellini, Mario Maggi, et al.
Journal of Endocrinological Investigation (2022) Vol. 46, Iss. 4, pp. 779-786
Open Access | Times Cited: 11

Need for Inclusive Consideration of Transgender and Gender Diverse People in E-Health Services: A Systematic Review
Janis Renner, Lars Täuber, Timo O. Nieder
Journal of Clinical Medicine (2022) Vol. 11, Iss. 4, pp. 1090-1090
Open Access | Times Cited: 10

Internalized transphobia predicts worse longitudinal trend of body uneasiness in transgender persons treated with gender affirming hormone therapy: a 1-year follow-up study
Giovanni Castellini, Eleonora Rossi, Emanuele Cassioli, et al.
The Journal of Sexual Medicine (2023) Vol. 20, Iss. 3, pp. 388-397
Open Access | Times Cited: 6

Update on bioethical, medical and fertility issues in gender incongruence during transition age
Anna Chiara Conflitti, Matteo Spaziani, Francesco Pallotti, et al.
Journal of Endocrinological Investigation (2023) Vol. 46, Iss. 9, pp. 1725-1736
Open Access | Times Cited: 6

Safety of gender affirming treatment in assigned female at birth transgender people and association of androgen and estrogen β receptor polymorphisms with clinical outcomes
Francesco Pallotti, Giulia Senofonte, Anna Chiara Conflitti, et al.
Endocrine (2023) Vol. 81, Iss. 3, pp. 621-630
Closed Access | Times Cited: 5

Body, metabolic and renal changes following cross-sex estrogen/progestogen therapy in a rodent model simulating its use by transwomen
J. V. Gusmão-Silva, Debora CK Lichtenecker, Lucas G. A. Ferreira, et al.
Journal of Endocrinological Investigation (2022) Vol. 45, Iss. 10, pp. 1875-1885
Closed Access | Times Cited: 8

Metabolic Features of Assigned Female at Birth Transgender People on Gender-Affirming Hormone Therapy: A Meta-analysis
Daniele Tienforti, Chiara Castellini, Francesca Di Giulio, et al.
Transgender Health (2023) Vol. 9, Iss. 6, pp. 466-483
Closed Access | Times Cited: 4

Getting old in the desired gender: a systematic review on aging diseases in transgender people
Chiara Ceolin, Mario Virgilio Papa, Antonio Scala, et al.
Journal of Endocrinological Investigation (2024) Vol. 47, Iss. 8, pp. 1851-1862
Open Access | Times Cited: 1

Epigenetic Effects of Gender-Affirming Hormone Treatment: A Pilot Study of the ESR2 Promoter’s Methylation in AFAB People
Francesco Pallotti, Giulia Senofonte, Fanì Konstantinidou, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 459-459
Open Access | Times Cited: 6

Promoting Human Rights standards for lesbian, gay, bisexual, and transgender people from the perspective of International law
Thomas A. Edison, Chen Liu, Tom Hank
International Journal of Multidisciplinary Approach Research and Science (2023) Vol. 1, Iss. 01, pp. 1-17
Open Access | Times Cited: 2

Gender-affirming hormone treatment: friend or foe? Long-term follow-up of 755 transgender people
Daniele Santi, Giorgia Spaggiari, Lorenzo Marinelli, et al.
Journal of Endocrinological Investigation (2023) Vol. 47, Iss. 5, pp. 1091-1100
Closed Access | Times Cited: 2

Do we urologists know enough about gender minorities with prostate cancer?
Valter Javaroni
International braz j urol (2024) Vol. 50, Iss. 1, pp. 87-94
Open Access

Terapia ormonale di affermazione di genere nelle persone transgender e gender diverse
Alessia Romani, Carlotta Cocchetti, Jiska Ristori, et al.
L Endocrinologo (2024) Vol. 25, Iss. 2, pp. 190-195
Open Access

Risk of erythrocytosis in transgender individuals undergoing testosterone therapy: a systematic review
Alberto Scala, Andrea Graziani, Fabrizio Vianello, et al.
Minerva Endocrinology (2024) Vol. 49, Iss. 2
Closed Access

Terapia ormonale di affermazione di genere in soggetti transgender AFAB: effetti epigenetici e ruolo dei polimorfismi dei recettori degli androgeni e degli estrogeni
Francesco Pallotti, Alessandra Buonacquisto, Sara Pitton, et al.
L Endocrinologo (2024) Vol. 25, Iss. 4, pp. 380-386
Closed Access

Relevant mental health issues in the Spanish Law 4/2023 about people with sexual diversity
José Manuel Bertolín Guillén
Spanish Journal of Legal Medicine (2024) Vol. 50, Iss. 3, pp. 113-120
Closed Access

Page 1 - Next Page

Scroll to top